Why Akamai Stock Is Up Today

Anthropic will spend $11.6B over seven years on Akamai's cloud infrastructure, according to Akamai. The deal, contingent on meeting service requirements, is the largest in Akamai's history. Akamai expects $150M-$300M in 2027, growing to $1.7B annually by late 2028. Akamai will invest $5.5B to expand capacity and issued Anthropic a warrant for up to 5% of its stock.

Akamai Technologies signed a $11.6 billion deal to provide computing capacity to Anthropic over seven years. Shares rose over 20% in after-hours trading. Anthropic may add $9 billion, expanding the deal to $20 billion, and has an option to acquire up to 5% of Akamai's shares. Akamai's CEO cited its large-scale AI infrastructure capabilities as the reason for the partnership.

Akamai has signed a 7-year deal with Anthropic for $11.6B in cloud services, potentially expanding to $20B. The deal requires $5.5B in upfront capital spending. Revenue recognition is expected from 2027, with a run rate of $1.7B/year. Akamai issued a warrant for up to 5% of its stock, vesting based on expansion. The deal does not change 2026 revenue guidance.

Anthropic signed a $11.6B, 7-year cloud contract with Akamai, with potential for an additional $9B. Akamai will provide AI infrastructure and software, and issued Anthropic a warrant for up to 5% of its stock. Akamai expects $5.5B in capital expenditures, with no impact on 2026 revenue guidance. Shares surged in after-hours trading.

AMD's shares surged 10%, reaching a $1 trillion market cap, driven by AI chip demand. Meta's Muse AI app boosted its stock. Moderna rallied 30% on cancer vaccine data. Akamai gained 15% after a $11.6B deal with Anthropic. Treasury yields hit 19-year highs, testing rally staying power.

Akamai (AKAM) announced an $11.6B deal with Anthropic, boosting revenue and capex estimates according to RBC. Guggenheim raised its price target to $225. Retail sentiment improved to 'extremely bullish'. AKAM stock is up over 30% YTD.